Royalty Pharma Plc Cl A (RPRX)

Jan 15, 2025, 3:49 AM EST - 2 days ago

Royalty Pharma: Key Strategic Updates To Be Priced In

Jan 10, 2025, 7:31 AM EST - 7 days ago

Royalty Pharma simplifies corporate structure with $1.1 bln deal

Jan 10, 2025, 7:30 AM EST - 7 days ago

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference

Jan 10, 2025, 7:15 AM EST - 7 days ago

Royalty Pharma Announces Transformative Step in Company's Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program

Jan 9, 2025, 4:15 PM EST - 8 days ago

Royalty Pharma Announces Dividend Increase

Nov 27, 2024, 4:15 PM EST - 7 weeks ago

Royalty Pharma to Present at Upcoming Investor Conferences

Nov 16, 2024, 8:00 AM EST - 2 months ago

Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +

ACB FREY TALO CAAP CASY DLO EME

Nov 14, 2024, 4:30 PM EST - 2 months ago

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

Nov 9, 2024, 12:46 AM EST - 2 months ago

Royalty Pharma: Massive Opportunity Ahead

Nov 7, 2024, 7:10 AM EST - 2 months ago

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million

Nov 6, 2024, 12:28 PM EST - 2 months ago

Royalty Pharma plc (RPRX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 8:39 AM EST - 2 months ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

JNJ MDT

Nov 6, 2024, 7:15 AM EST - 2 months ago

Royalty Pharma Reports Third Quarter 2024 Results

Nov 4, 2024, 4:15 PM EST - 2 months ago

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo

Nov 4, 2024, 4:01 PM EST - 2 months ago

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™

SNDX

Oct 16, 2024, 4:15 PM EDT - 3 months ago

Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024

Oct 11, 2024, 8:15 AM EDT - 3 months ago

Royalty Pharma Declares Fourth Quarter 2024 Dividend

Sep 3, 2024, 5:14 PM EDT - 4 months ago

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement

Aug 28, 2024, 4:15 PM EDT - 5 months ago

Royalty Pharma to Present at Morgan Stanley's 22nd Annual Global Healthcare Conference

Aug 22, 2024, 3:04 AM EDT - 5 months ago

Royalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy Rating

Aug 11, 2024, 6:33 PM EDT - 5 months ago

Royalty Pharma: Busy Putting Capital To Work

Aug 8, 2024, 2:14 PM EDT - 5 months ago

Royalty Pharma plc (RPRX) Q2 2024 Earnings Call Transcript

Jul 24, 2024, 8:30 AM EDT - 6 months ago

Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital

Jul 19, 2024, 8:15 AM EDT - 6 months ago

Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024

Jul 17, 2024, 4:15 PM EDT - 6 months ago

Royalty Pharma Declares Third Quarter 2024 Dividend

Jun 4, 2024, 4:15 PM EDT - 8 months ago

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 3, 2024, 5:15 PM EDT - 8 months ago

Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes

May 28, 2024, 7:10 AM EDT - 8 months ago

Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million

May 22, 2024, 4:10 PM EDT - 8 months ago

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

May 9, 2024, 1:32 PM EDT - 9 months ago

Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript

May 9, 2024, 6:45 AM EDT - 9 months ago

Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab

May 2, 2024, 4:01 PM EDT - 9 months ago

Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma

ARWR

Apr 19, 2024, 8:15 AM EDT - 9 months ago

Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024

Apr 17, 2024, 8:15 AM EDT - 9 months ago

Royalty Pharma Declares Second Quarter 2024 Dividend

Feb 28, 2024, 4:15 PM EST - 11 months ago

Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference

Feb 15, 2024, 1:39 PM EST - 1 year ago

Royalty Pharma PLC (RPRX) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 7:30 AM EST - 1 year ago

Royalty Pharma Reports Q4 and Full Year 2023 Results

Jan 30, 2024, 4:15 PM EST - 1 year ago

Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024

Jan 22, 2024, 7:13 AM EST - 1 year ago

Royalty Pharma: One Of The Best Names In Pharmaceuticals

Nov 27, 2023, 4:15 PM EST - 1 year ago

Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference

Nov 13, 2023, 9:38 AM EST - 1 year ago

MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)

TEVA

Nov 13, 2023, 8:10 AM EST - 1 year ago

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program

Nov 13, 2023, 8:00 AM EST - 1 year ago

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program

Nov 8, 2023, 12:57 PM EST - 1 year ago

Royalty Pharma PLC (RPRX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 7:00 AM EST - 1 year ago

Royalty Pharma Reports Third Quarter 2023 Results

Oct 19, 2023, 8:19 AM EDT - 1 year ago

Royalty Pharma to pay $1 bln for Roche's SMA drug royalties

Oct 19, 2023, 7:59 AM EDT - 1 year ago

Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi

Oct 16, 2023, 4:15 PM EDT - 1 year ago

Royalty Pharma Declares Fourth Quarter 2023 Dividend

Oct 11, 2023, 4:15 PM EDT - 1 year ago

Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023

Sep 27, 2023, 2:15 AM EDT - 1 year ago

Royalty Pharma: The Time Has Come